UBS OCONNOR LLC - OREXIGEN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$2,550,000,000
-15.0%
7,500,0000.0%0.04%
+2.3%
Q3 2017$3,000,000,0000.0%7,500,0000.0%0.04%
-10.2%
Q2 2017$3,000,000,0000.0%7,500,0000.0%0.05%
-3.9%
Q1 2017$3,000,000,0007,500,0000.05%
Other shareholders

There were no reported owners of OREXIGEN THERAPEUTICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of OREXIGEN THERAPEUTICS INC shareholders